Univest
Univest
  • Markets

Yatharth Hospital & Trauma Care Services Share Price Target 2027, 2028 and 2030: Long Term Analyst Forecast

  • August 17, 2026
  • Posted by: Ankit Jaiswal
  • Category: Market
No Comments
Yatharth Hospital & Trauma Care Services Share Price Target 2027, 2028 and 2030: Long Term Analyst Forecast

Yatharth Hospital & Trauma Care Services analyst target 2027: Rs 580 (-31%). 2028: Rs 685. Long-term target 2030: Rs 955 (+14%). CMP Rs 841.3.

Quick Answer

The Yatharth Hospital & Trauma Care Services share price target for 2027 is Rs 580, which sits around 31 percent below the current price of Rs 841.3. Analysts expect a stronger recovery from 2028, with the target rising to Rs 685 before reaching Rs 955 by 2030 , a potential gain of approximately 14 percent from today’s levels. Assuming approximately18% annual earnings growth off a FY26 base EPS of ₹9.8 and a fair multiple of approximately50x (mo. Investors considering Yatharth Hospital & Trauma Care Services should weigh the 2030 upside case against the near-term consolidation phase and the sector-specific risks outlined below.

Yatharth Hospital & Trauma Care Services is trading at Rs 841.3 with near-term consolidation expected , the 2027 target of Rs 580 is approximately 31 percent below the current price. The more compelling case is in the outer years , Rs 685 by 2028 and Rs 955 by 2030 , as the earnings model builds toward that trajectory. Assuming approximately18% annual earnings growth off a FY26 base EPS of ₹9.8 and a fair multiple of approximately50x (moderating to approximately14% growth long-term), the stock’s valuation trend poin.

This article breaks down the Yatharth Hospital & Trauma Care Services share price target for 2027, 2028, and 2030, the sector-specific drivers behind the analyst model, and the risks that could delay or derail the forecast.

Click Here – Get Free Investment Predictions

Table of Contents

Toggle
  • Yatharth Hospital & Trauma Care Services Company Overview and Share Price Target Summary
  • Why Analysts Have Set the Yatharth Hospital & Trauma Care Services share price target at Rs 580 for 2027
    • Domestic Formulations Revenue Is Growing Ahead of Sector
    • Export Markets and Regulatory Compliance Give Revenue Visibility
    • New Product Approvals Will Drive the Next Leg of Growth
    • Manufacturing Scale Keeps Cost Structures Competitive
    • India’s Healthcare Spending Is Compounding at Above-GDP Rates
  • Yatharth Hospital & Trauma Care Services Share Price Target 2027, 2028 and 2030: Year-Wise Breakdown
    • 2027 Target: Rs 580
    • 2028 Target: Rs 685
    • 2030 Target: Rs 955
  • Bull Case and Bear Case for Yatharth Hospital & Trauma Care Services by 2030
    • Bull Case: Rs 1,222
    • Bear Case: Rs 716
  • Key Risks to the Yatharth Hospital & Trauma Care Services Forecast
    • Regulatory Risk
    • Currency Headwind
    • Generic Pricing Pressure
    • Pipeline Delays
  • How to Invest in Yatharth Hospital & Trauma Care Services
  • Conclusion
  • Frequently Asked Questions on Yatharth Hospital & Trauma Care Services Share Price Target 2027 2028 and 2030
    • What is the Yatharth Hospital & Trauma Care Services share price target for 2027?
    • What is the Yatharth Hospital & Trauma Care Services share price target for 2030?
    • What is the Yatharth Hospital & Trauma Care Services share price target for 2028?
    • Is Yatharth Hospital & Trauma Care Services a good long-term investment?
    • What are the key risks to the Yatharth Hospital & Trauma Care Services analyst forecast?
    • What is the bull case for Yatharth Hospital & Trauma Care Services by 2030?
    • What sector does Yatharth Hospital & Trauma Care Services belong to?
    • How can I track and invest in Yatharth Hospital & Trauma Care Services?

Yatharth Hospital & Trauma Care Services Company Overview and Share Price Target Summary

Metric Details
NSE Ticker YATHARTH
Sector Pharma and Healthcare
CMP (14 Aug 2026) Rs 841.3
Market Cap Rs 8100 Cr
12M Consensus ₹986 (+17%)
Yatharth Hospital & Trauma Care Services Share Price Target 2027 Rs 580 (-31%)
Yatharth Hospital & Trauma Care Services Share Price Target 2028 Rs 685 (-19%)
Yatharth Hospital & Trauma Care Services Share Price Target 2030 Rs 955 (+14%)
Bull Case 2030 Rs 1,222
Bear Case 2030 Rs 716

What most investors miss about Yatharth Hospital & Trauma Care Services: Promoters have pledged 10.73% of their stake – a notable pledge risk for an otherwise growth-oriented hospital chain; analyst consensus (4 analysts) averages Rs986 target (range Rs950-1050), implying approximately17% upside from recent price

Assuming approximately18% annual earnings growth off a FY26 base EPS of ₹9.8 and a fair multiple of approximately50x (moderating to approximately14% growth long-term), the stock’s valuation trend points to the figures above. Street consensus (1-yr) sits at ₹986..

Why Analysts Have Set the Yatharth Hospital & Trauma Care Services share price target at Rs 580 for 2027

Domestic Formulations Revenue Is Growing Ahead of Sector

This is the clearest reason the analyst model converges on Rs 955 by 2030. Assuming approximately18% annual earnings growth off a FY26 base EPS of ₹9.8 and a fair multiple of approximately50x (mo. Tracking this factor quarterly gives the earliest signal on whether the long-term analyst target stays on course.

Export Markets and Regulatory Compliance Give Revenue Visibility

The Yatharth Hospital & Trauma Care Services share price target for 2028 , Rs 685 , is built partly on this continuing to hold. If it deteriorates, the timeline for the outer-year forecast extends, not the target itself. Investors should track it with every results cycle.

New Product Approvals Will Drive the Next Leg of Growth

This underpins Yatharth Hospital & Trauma Care Services’s growth beyond the 2027 near-term. It is the kind of durable structural factor that keeps analysts positive on the 2030 target even when quarterly numbers disappoint.

Manufacturing Scale Keeps Cost Structures Competitive

For the 2028 recovery thesis to work, Yatharth Hospital & Trauma Care Services needs to maintain consistency here. One cycle of weakness would not break the long-term case, but two consecutive quarters of deterioration would prompt downgrades.

India’s Healthcare Spending Is Compounding at Above-GDP Rates

This is the macro layer that most company-specific screens miss. It amplifies Yatharth Hospital & Trauma Care Services’s own earnings compounding and is why analysts are more constructive on the 2030 horizon than on 2027.

Yatharth Hospital & Trauma Care Services Share Price Target 2027, 2028 and 2030: Year-Wise Breakdown

2027 Target: Rs 580

Rs 580 is the 2027 analyst target, implying near-term consolidation expected , the 2027 target of Rs 580 is approximately 31 percent below the current price. At this level, Yatharth Hospital & Trauma Care Services would be trading on forward multiples consistent with the current earnings trajectory. The 2027 milestone is essentially a staging post , confirmed only after two to three quarters of on-track delivery.

2028 Target: Rs 685

Rs 685 is where analysts see Yatharth Hospital & Trauma Care Services by 2028, roughly -19 percent above today’s price. By FY29, the business should have moved past the near-term consolidation, and the Yatharth Hospital & Trauma Care Services share price target for 2028 typically re-rates faster than markets initially expect once the earnings inflection becomes visible.

2030 Target: Rs 955

The long-term case is Rs 955 by 2030 , a potential gain of approximately 14 percent from CMP Rs 841.3, which works out to a 4-year CAGR of roughly 3 percent. By FY31, Yatharth Hospital & Trauma Care Services should be operating at a scale and earnings quality that justifies the multiple implied by this target. Please verify all data at NSE and BSE before making any investment decision.

Bull Case and Bear Case for Yatharth Hospital & Trauma Care Services by 2030

Bull Case: Rs 1,222

The bull case lands at Rs 1,222 by 2030. This requires better-than-expected earnings growth alongside a re-rating of the multiple , both need to land together. Favourable macro conditions, new business wins, or a sector re-rating could drive this scenario without needing extraordinary operational delivery from the company.

Bear Case: Rs 716

The bear case is Rs 716 by 2030 , still above today’s price in most scenarios, but a significantly slower path. This applies if earnings miss across FY27 to FY28, competitive pressure intensifies, or a macro slowdown compresses sector multiples before Yatharth Hospital & Trauma Care Services can re-rate upward.

Scenario Target 2030 Return Key Assumption
Bull Case Rs 1,222 +45% Above-consensus growth; multiple expansion
Base Case Rs 955 +14% Base-case CAGR; peer multiples hold
Bear Case Rs 716 -15% Earnings miss; macro pressure; multiple contraction

Key Risks to the Yatharth Hospital & Trauma Care Services Forecast

Regulatory Risk

A USFDA warning letter or facility import alert would delay US launches and compress the export revenue that drives the outer-year targets.

Currency Headwind

INR appreciation against USD reduces the INR value of Yatharth Hospital & Trauma Care Services’s foreign revenue without any change in business performance.

Generic Pricing Pressure

Pricing erosion in US generic markets, especially in key molecules, can shrink EBITDA margins faster than volume growth compensates.

Pipeline Delays

Clinical or regulatory delays in new product filings push revenue ramp timelines, affecting the 2028 and 2030 targets specifically.

How to Invest in Yatharth Hospital & Trauma Care Services

Start by tracking Yatharth Hospital & Trauma Care Services’s quarterly results against the model assumptions. The Univest Screener gives you live fundamentals, analyst upgrade history, and price alerts on NSE ticker YATHARTH , the same data points that drive the Yatharth Hospital & Trauma Care Services share price target model. Build positions in tranches across the 2027 to 2028 window rather than committing fully now, and consult a SEBI-registered financial advisor before investing.

Track This Stock Live on the Univest Screener

Conclusion

The Yatharth Hospital & Trauma Care Services share price target of Rs 580 for 2027, Rs 685 for 2028, and Rs 955 for 2030 reflects the analyst model built on Yatharth Hospital & Trauma Care Services’s earnings trajectory in the pharma and healthcare sector. The near-term picture is one of consolidation; the case for patient investors is in the 2028 to 2030 window. Always verify financial data at NSE India and BSE India before making any investment decision.

Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).

Download the Univest iOS App or Univest Android App to track Yatharth Hospital & Trauma Care Services share price live and get daily stock recommendations.

Frequently Asked Questions on Yatharth Hospital & Trauma Care Services Share Price Target 2027 2028 and 2030

What is the Yatharth Hospital & Trauma Care Services share price target for 2027?

Ans. The Yatharth Hospital & Trauma Care Services share price target for 2027 is Rs 580, which is approximately 31 percent slightly below the current market price of Rs 841.3. This near-term target reflects the analyst consensus as of August 2026. Verify all data at NSE India before investing.

What is the Yatharth Hospital & Trauma Care Services share price target for 2030?

Ans. The 2030 analyst target for Yatharth Hospital & Trauma Care Services is Rs 955, implying approximately 14 percent potential upside from CMP Rs 841.3. This is the base-case extrapolation from the current earnings growth model. These are analyst estimates and not guaranteed returns.

What is the Yatharth Hospital & Trauma Care Services share price target for 2028?

Ans. The Yatharth Hospital & Trauma Care Services share price target for 2028 is Rs 685, approximately -19 percent from the current price. By FY29, the business should be past the near-term consolidation phase, which makes the 2028 target more realistically achievable than the 2027 level.

Is Yatharth Hospital & Trauma Care Services a good long-term investment?

Ans. Yatharth Hospital & Trauma Care Services has a defined earnings growth thesis in the pharma and healthcare sector, with targets that project meaningful upside by 2030. Whether it suits your portfolio depends on your risk appetite, investment horizon, and current allocation. Speak with a SEBI-registered financial advisor before deciding.

What are the key risks to the Yatharth Hospital & Trauma Care Services analyst forecast?

Ans. The most significant risks are regulatory risk and currency headwind. Beyond these, broader macro slowdowns and sector-specific headwinds can compress multiples even when the company itself is executing well.

What is the bull case for Yatharth Hospital & Trauma Care Services by 2030?

Ans. The bull case target is Rs 1,222 by 2030. This requires above-consensus earnings growth and a re-rating of the PE multiple , both need to happen together. These are analyst projections, not guaranteed outcomes.

What sector does Yatharth Hospital & Trauma Care Services belong to?

Ans. Yatharth Hospital & Trauma Care Services operates in the pharma and healthcare sector. This sector classification influences the peer multiples applied in the analyst target model and the macro factors that most directly affect the company’s earnings outlook.

How can I track and invest in Yatharth Hospital & Trauma Care Services?

Ans. You can buy Yatharth Hospital & Trauma Care Services shares through any SEBI-registered broker using NSE ticker YATHARTH. The Univest Screener lets you track live fundamentals, set price alerts, and monitor analyst ratings. Always consult a SEBI-registered financial advisor before investing.



News
Author: Ankit Jaiswal
Ankit Jaiswal is the Senior Research Analyst at Univest, leading the platform's in-house equity research desk and serving as the editorial reviewer for all research and blog content published at univest.in. With 11+ years of experience in Indian equity markets, he oversees stock recommendations, earnings analysis, sector coverage, and ensures every published article meets SEBI Research Analyst Regulations. He holds a Bachelor of Commerce (B.Com) from St. Xavier's College, Kolkata — one of India's most prestigious commerce institutions — and has cleared CMT Level 2 from the CMT Association, a globally recognised certification in technical analysis and market research. His research methodology combines fundamental analysis (earnings quality, balance sheet strength, management commentary) with advanced technical analysis (chart patterns, momentum indicators, market structure) — giving Univest's retail investors a dual-lens approach that most Indian research platforms lack. Ankit is among the most comprehensively certified analysts in Indian financial media, holding five NISM certifications: Series-XV (Research Analyst), Series-VIII (Equity Derivatives), Series-VII (SORM), Series-VI (Depository Operations), and Series-V-A (Mutual Fund Distributors). At Univest — India's SEBI-registered research and advisory platform — Ankit's responsibilities include leading the research team, finalising stock recommendations published across Pro Lite, Pro Super, and Pro Gold advisory services, and maintaining editorial oversight of all YMYL financial content published on the blog.

Leave a Reply Cancel reply